Increased β‐catenin nuclear localisation, as well as increased mRNA levels of downstream effector Axin2 and TCF1 in AL008 supernatant‐treated HCC cells suggested increased Wnt/β‐catenin activity (Figure 5C and D). The gene discussed is AXIN2; the disease is hepatocellular carcinoma.